Literature DB >> 7153897

Protein binding of caffeine in young and elderly males.

J Blanchard.   

Abstract

The plasma protein binding of caffeine in young and elderly males was evaluated using an ultrafiltration technique. In spite of a significantly lower plasma albumin concentration in the elderly subjects the observed percent bound (approximately 35%) was essentially identical in both subject groups. The binding of caffeine to human plasma albumin (4.5% w/v) in vitro was also examined using ultracentrifugation and it was observed to be bound to the extent of 37.8%. In both the plasma and albumin binding studies the free fraction remained constant over the range of concentrations examined. Although there was no apparent correlation between the percent bound and the albumin concentration in the plasma of either subject group the close agreement between the degree of binding of caffeine to albumin and human plasma indicates that albumin is likely the major plasma binding protein for caffeine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7153897     DOI: 10.1002/jps.2600711229

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  17 in total

Review 1.  Age-related changes in protein binding of drugs: implications for therapy.

Authors:  M K Grandison; F D Boudinot
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

2.  Enhanced brain amyloid-β clearance by rifampicin and caffeine as a possible protective mechanism against Alzheimer's disease.

Authors:  Hisham Qosa; Alaa H Abuznait; Ronald A Hill; Amal Kaddoumi
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 3.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics of non-opiate abused drugs.

Authors:  U Busto; R Bendayan; E M Sellers
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

Review 5.  Plasma protein binding of drugs in the elderly.

Authors:  S M Wallace; R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

6.  Impairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives.

Authors:  D R Abernethy; E L Todd
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  Pregnancy-induced changes in the pharmacokinetics of caffeine and its metabolites.

Authors:  Tian Yu; Sarah C Campbell; Chris Stockmann; Casey Tak; Katherine Schoen; Erin A S Clark; Michael W Varner; Michael G Spigarelli; Catherine M T Sherwin
Journal:  J Clin Pharmacol       Date:  2015-12-22       Impact factor: 3.126

8.  Caffeine Blocks HIV-1 Tat-Induced Amyloid Beta Production and Tau Phosphorylation.

Authors:  Mahmoud L Soliman; Jonathan D Geiger; Xuesong Chen
Journal:  J Neuroimmune Pharmacol       Date:  2016-09-15       Impact factor: 4.147

9.  Variability of the serum protein binding of theophylline in patients with asthma and cystic fibrosis.

Authors:  J Blanchard; S Harvey; W J Morgan
Journal:  Br J Clin Pharmacol       Date:  1992-06       Impact factor: 4.335

10.  Comparative pharmacokinetics of caffeine in young and elderly men.

Authors:  J Blanchard; S J Sawers
Journal:  J Pharmacokinet Biopharm       Date:  1983-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.